Navigation Links
Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer

ophage in ex-US markets.

Conference Call Information

Antigenics executives and Dr. Christopher Wood will host a conference call at 1:30 pm ET today. To access the live call, dial 888.271.9082 (domestic) or 706.679.7741 (international); the access code is 9197359. The call will also be webcast and will be accessible from the company's website at www.antigenics.com/webcast/. A replay will be available approximately two hours after the call through midnight ET on June 4, 2007. The replay number is 800.642.1687 (domestic) or 706.645.9291 (international), and the access code is 9197359. The replay will also be available on the company's website approximately two hours after the live call.

About Renal Cell Carcinoma

Renal cell carcinoma is the most common type of kidney cancer. The American Cancer Society estimates that there will be approximately 51,190 new cases of kidney cancer in the United States in 2007, and about 12,890 people will die from the disease. Renal cell carcinoma accounts for about 90 percent of all kidney tumors. By the time renal cell carcinoma is diagnosed in these patients, about one third of them will have developed metastatic disease.

The current standard of care for patients with nonmetastatic renal cell carcinoma consists of a nephrectomy (surgical removal of the kidney) followed by observation. There is no treatment approved by the US Food and Drug Administration for nonmetastatic renal cell carcinoma at the present time.

*Haas N. Update on targeted therapy adjuvant trials (ECOG/MRC). Paper presented at: Fifth International Symposium of the Kidney Cancer Association, 2006; Chicago.

About Antigenics

Antigenics (NASDAQ: AGEN) is a biotechnology company working to develop treatments for cancers and infectious diseases. The company's investigational product portfolio includes Oncophage(R) (vitespen), a patient-specific therapeutic cancer vaccine being evaluated in several indications; Aroplatin
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Data from Investigator-Sponsored Trial of Oncophage Cancer Vaccine in Glioma Presented at American Association of Neurological Surgeons Annual Meeting
2. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
3. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
4. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
5. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
6. Protox Announces Positive Clinical Data from Prostate Cancer Study
7. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
8. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
9. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
10. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
11. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer

Post Your Comments:
(Date:11/25/2009)...Colo., Nov. 25 Heska Cor... advanced diagnostic and specialty products to t... with Roche Diagnostics Corporation for the supply...for the veterinary market. ,, (Logo: http:...) ,, "Heska and Roche share the same passion fo...
(Date:11/25/2009)...TAFA, Switzerland, Nov. 25 From N... innovative hearing solutions, presented the secon...e, focusing on the special needs of the older popu...perts in aging and audiology from around the world...th older people with hearing loss for an opportuni...
(Date:11/25/2009)...K, Md., Nov. 25 Remediu...g cream-like foam that stops severe bleeding, won ...rity Idea category of the Global Security Challeng...lected from more than 100 entries from around the ...the GSC Security Summit conference held at the Lon...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3AFSCME President McEntee 3A 22Finance Committee Health Care Bill is Deeply Flawed 22 57421 1For the Color Blind a Ray of Hope 57416 1For the Color Blind a Ray of Hope 57416 2Prime Staffing Awarded Certification from The Joint Commission 57411 1Prime Staffing Awarded Certification from The Joint Commission 57411 2
...med,Pharmaceuticals, Inc. (OTCBB: ORMP.OB), a deve...ced today that it has concluded a proof of concept...RMD-0802, using its,proprietary technology. Eight ...ifferent formulations. , The insulin supposito...glucose lowering effect. The suppositories were we...
... Indication is June 3, 2009 - , , EXTON, Pa., Fe...orated (Nasdaq: VPHM ) today announced that the ...d priority review for Cinryze C1 Inhibitor (human)...gioedema (HAE). The supplemental Biologics Licens...mber 1, 2008, was based on a re-analysis and resu...
Other Medicine Technology:Oramed Pharmaceuticals Completes Proof of Concept Study of Insulin Suppository 2FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 2FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 3FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 4FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 5FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE) 6
(Date:11/27/2009)... new interactive anatomy education apps from Modal...ealth sciences learning opportunities for iPhone a...C (Vocus) November 27, 2009 -- Modality, Inc. an...ion of Wolters Kluwer Health, today announced the ...n the App Store. Clemente’s Anatomy, Rohen&r...
(Date:11/26/2009)...tetrathiomolybdate (TM) has been shown in studies ..., a disease caused by an overload of copper, and c...y little, however, is known about how the drug wor...Northwestern University researchers now has provid...ture of TM bound to copper-loaded metallochaperone...
(Date:11/26/2009)...avid Kim of the Live Life Again Center, a practice...of a growing number of physicians who are taking ...nnect with individuals who are interested in surgi... Dr. Kim is utilizing Facebook to share before-and...ith the community. , Dall...
(Date:11/25/2009)...25 When most people hea...ut a chiropractor can also give patients the help ...Joint, which is where your jaw (mandible) contacts...The most common symptoms associated with TMJ dysfu...of the jaw. But many other symptoms can be caused...
(Date:11/25/2009)...RNewswire/ - Sentinelle Medical Inc., a leading ma...ization software launches a suite of new leading e... imaging software platform at this year,s Radiolog...g in Chicago, Nov. 30 - Dec. 5, 2009 (Booth 5800, ... quality images generated by Sentinelle,s speciali...
Breaking Medicine News(10 mins):Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 4
... 10 CMP India and CMP Information,The Netherlands...y,International Exhibition and Conference on Food ... is a part of the world-wide series of Fi Events,h...eptember 2006 for the first time and,was inaugurat...
...vide the most effective treatments for cancer pati...ive and specific early detection of the disease. ...Glycobiology Laboratory at UCD has developed a sys... which are attached either to proteins made by can...
... 9 Today, Congresswoman,Stephanie Tubbs Jones app...ents for Patients and Providers Act by a veto-proo..., "I am ecstatic that my Senate colleagues passed...viding continuing,protections to ensure access by ...
...uly 9 A lawsuit charges,pharmaceutical giant Pfiz...he public of potentially deadly side-effects assoc...nicline which is marketed under the trade name,Cha...death occurred only a few days before the informat...
...ay point to new targets for treatment, study says ...A gene mutation linked to one family,s hereditary ...ind better ways to predict, prevent and treat the ... large family with an inherited form of atrial fib...
...J. Wilson, President and CEO of the American,Assoc...ble medical,equipment manufacturers and providers ...icials at the revelations that scam artists used i...presented by,the American Association for Homecare...
Other Medicine News:Health News:CMP is Back This Year with Loads of Innovative Ideas and Varieties of Food Ingredients 2Health News:A short and sweet diagnosis for cancer? 2Health News:Chantix Blamed for Suicide in Lawsuit Against Pfizer Filed by Cory Watson Crowder & DeGaris 2Health News:Gene Mutation Tied to Inherited Atrial Fibrillation 2Health News:Home Medical Equipment Providers Are Appalled by 'Dead-Doctor' Scam, Strongly Support Anti-Fraud Efforts to Protect Medicare System 2Health News:Home Medical Equipment Providers Are Appalled by 'Dead-Doctor' Scam, Strongly Support Anti-Fraud Efforts to Protect Medicare System 3
...precise requirements of blood banking and processi... meets American Association of Blood Banks (AABB),...& Drug Administration (FDA) standards. Refrigerato...ure alarm systems that alert you of critical power...
Blood Storage Refrigerator TBR-200-1-GD
Testosterone ELISA
Ultra-Sensitive Testosterone EIA
Medicine Products: